PIMA512421
CA19-9 Monoclonal Antibody (116-NS-19-9), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA512421-Each-of-1 | In Stock | ₹ 56,159.00 |
PIMA512421 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 56,159.00
GST (18%): ₹ 10,108.62
Total Price: ₹ 66,267.62
Antigen
CA19-9
Classification
Monoclonal
Concentration
Conc. Not Determined
Formulation
tissue culture supernatant with 0.09% sodium azide
Host Species
Mouse
Quantity
500 μL
Primary or Secondary
Primary
Content And Storage
4° C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin)
Clone
116-NS-19-9
Conjugate
Unconjugated
Gene Alias
CA19 9; CA19.9; CA-19.9
Immunogen
Human colon carcinoma cell line SW1116
Regulatory Status
RUO
Target Species
Human
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- MA5-12421 targets CA19-9 in IHC (P) applications and shows reactivity with Human samples
- The MA5-12421 immunogen is human colon carcinoma cell line SW1116
- Mucin glycoprotein is a Sialyl Lewis A structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewis A and/or Lewis B blood group antigens
- In normal tissues, sialyl Lewis A antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands
- Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas
- Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery
- When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings.